Literature DB >> 109783

Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey.

D L Murphy, D E Redmond, N Garrick, J Baulu.   

Abstract

Monoamine oxidase in the vervet monkey showed greater variations in activity in six brain regions when tyramine or phenylethylamine was used as the substrate (3.8- to 4.1-fold differences) than when serotonin was the substrate (1.8-fold differences). With phenylethylamine and tyramine as substrates, the highest MAO specific activities were found in the hypothalamus and the lowest in the cerebellum and cortex. With serotonin as the substrate, the highest specific activities were in the mesencephalon and cortex. The inhibition of tyramine deamination by clorgyline and deprenyl yielded biphasic plots indicative of the presence of MAO-A and MAO-B enzyme forms in the vervet brain. On the basis of these inhibitor curves, the vervet brain could be estimated to contain approximately 85% MAO-B and 15% MAO-A, in contrast to rat brain which contains 45% MAO-B and 5% MAO-A. The inhibition of serotonin deamination by deprenyl in vervet brain yielded a biphasic plot, suggesting that some serotonin deamination in the vervet is accomplished by the MAO-B enzyme form. Estimations of the relative amounts of MAO-A and MAO-B based on inhibitor curves or based on substrate ratios yielded proportionate results which were in close agreement across the different brain regions, supporting the validity of these approaches to estimating MAO-A and MAO-B activities.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109783     DOI: 10.1007/bf00963831

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

Review 1.  Multiple forms of monoamine oxidase: fact and artefact.

Authors:  M D Houslay; K F Tipton
Journal:  Life Sci       Date:  1976-08-15       Impact factor: 5.037

2.  Studies on the monoamine oxidase of monkey brain.

Authors:  A Oommen; A S Balasubramanian
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

3.  Regional distribution of monoamine oxidase activity for 5-hydroxytryptamine and tyramine in hypothalamus of the rat.

Authors:  M Hirano; H Uchimura; M Saito
Journal:  Brain Res       Date:  1975-08-15       Impact factor: 3.252

4.  Monoamine oxidase activities towards biogenic monoamines in several regions of rat brain.

Authors:  M Harada; Y Kondo; H Kuzuya; T Nagatsu
Journal:  J Neurochem       Date:  1975-01       Impact factor: 5.372

5.  Distribution of catechol-O-methyltransferase, histamine N-methyltransferase and monoamine oxidase in specific areas of the rat brain.

Authors:  J M Saavedra; M J Brownstein; M Palkovits
Journal:  Brain Res       Date:  1976-12-10       Impact factor: 3.252

6.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

Review 7.  Substrate-selective monoamine oxidases--inhibitor, tissue, species and functional differences.

Authors:  D L Murphy
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

8.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

Authors:  J P Johnston
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

9.  Dopamine is a monoamine oxidase B substrate in man.

Authors:  V Glover; M Sandler; F Owen; G J Riley
Journal:  Nature       Date:  1977-01-06       Impact factor: 49.962

10.  Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa.

Authors:  J W Maas; H Dekirmenjian; D Garver; D E Redmond; D H Landis
Journal:  Eur J Pharmacol       Date:  1973-08       Impact factor: 4.432

View more
  9 in total

1.  Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors:  R Heintz; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine.

Authors:  Mari S Golub; Casey E Hogrefe; Alicia M Bulleri
Journal:  Neuropharmacology       Date:  2016-02-22       Impact factor: 5.250

Review 3.  Systems biology of the vervet monkey.

Authors:  Anna J Jasinska; Christopher A Schmitt; Susan K Service; Rita M Cantor; Ken Dewar; James D Jentsch; Jay R Kaplan; Trudy R Turner; Wesley C Warren; George M Weinstock; Roger P Woods; Nelson B Freimer
Journal:  ILAR J       Date:  2013

4.  A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.

Authors:  Sevil Yasar; József Gaál; Leigh V Panlilio; Zuzana Justinova; Szecsö V Molnár; Godfrey H Redhi; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

5.  Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.

Authors:  N A Garrick; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  Localization of monoamine oxidases A and B in primate brains relative to neuron-specific and non-neuronal enolases.

Authors:  I C Campbell; P J Marangos; A Parma; N A Garrick; D L Murphy
Journal:  Neurochem Res       Date:  1982-06       Impact factor: 3.996

7.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

Review 8.  The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog.

Authors:  N W Milgram; G O Ivy; E Head; M P Murphy; P H Wu; W W Ruehl; P H Yu; D A Durden; B A Davis; I A Paterson
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

9.  Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.

Authors:  Y Koide; K Kobayashi
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.